Dr. Priyabrata Pattnaik

Dr. Priyabrata Pattnaik |Clyto Access

Worldwide Vaccine Initiative Merck, Singapore

Editorial Board Member
priyabrata.pattnaik@merckgroup.com

Expertise: Vaccine bioprocessing, Biomanufacturing, Vaccine process development, process monitoring, scale-up

Bio: Dr. Priyabrata Pattnaik is Director of Worldwide Vaccine Initiative of Merck.  He is global technical/market lead for vaccine initiative supporting R&D and integrated solutions for vaccines and a thought leader on vaccine technology. He was head of Biomanufacturing Sciences and Training Centre at Singapore and lead a group of process engineers providing consulting services, educational seminars and applications support. Dr. Pattnaik worked as a Scientist at International Centre for Genetic Engineering and Biotechnology (United Nations), New Delhi for Malaria Vaccine Initiative [MVI] developing malaria vaccines. Later moved to Defence R&D Organization, Govt. of India to lead the biodefence vaccine program. He was principal investigator for several vaccine projects and awarded by Indian govt with Brig. KM Rao award for his contribution on dengue vaccine development. He also supervised graduates and PhD students and lectured in several universities. He is the co-author of more than 85 publications in international journals and eight book chapters. He is also member of many scientific associations and in reviewer panel of several international journals. Priyabrata Pattnaik graduated at the Utkal University of Orissa, received master degree in Microbiology from Orissa University of Agriculture and Technology, and awarded PhD in Microbiology from National Dairy Research Institute, India.

Related Journals & Conferences :

International Journal of Vaccines and Technologies